Glatiramer acetate - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Glatiramer acetate: Anaphylactic reactions may occur months up to years after treatment initiation

Dissemination date: 14/08/2024

Key facts

• Active substance:
  Glatiramer acetate
• Therapeutic area (MeSH):
  Multiple Sclerosis
• Procedure number:
  PSUSA/00001529/202311
• Regulatory outcome:
  Variation
• DHPC type:
  Adverse event
• Human ATC codes:
  L03AX13
• Dissemination date:
  14/08/2024
• Related medicines:
  Glatiramer acetate